$GUTS SEC Filings

Filed On	Filing
22 Oct 2026	8-K: Cost Associated with Exit or Disposal Activities; Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers +1 more Fractyl Health Sharpens Focus on Revita Following Positive Pivotal Results, Advancing Toward Planned FDA De Novo Submission in Post-GLP-1 Weight Maintenance
16 Oct 2026	8-K: Regulation FD Disclosure; Other Events October 2026 REMAIN-1 Pivotal Study Positive Topline 6 Month Results for Revita in Post-GLP-1 Weight Maintenance Revita is for investigational use only in the United States. Revita has a CE mark in the EU/UK. REMAIN-1 is an ongoing study...
13 Oct 2026	SCHEDULE 13G
01 Oct 2026	8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Fractyl Health, Inc., a corporation organized and existing under the General Corporation Law of the State of Delaware (the “DGCL”), certifies:
24 Sep 2026	8-K: Submission of Matters to a Vote of Security Holders On September 24, 2026, Fractyl Health, Inc. (the “Company”) held its Special Meeting of Stockholders (the “Special Meeting”). Of the 159,179,848, shares of the Company’s common stock outstanding as of the record date of August 21, 2026, ...
16 Sep 2026	Form 4: Bradley William, Director Bought 64,516 shares ($39.9K)
11 Sep 2026	8-K: Notice of Delisting or Failure to Satisfy a Listing Rule As previously disclosed, on March 13, 2026, Fractyl Health, Inc. (the “Company”) received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that the listing of its common ...
24 Aug 2026	Proxy statement: special meeting on September 24, 2026
14 Aug 2026	PRE 14A
10 Aug 2026	10-Q
10 Aug 2026	8-K: Results of Operations and Financial Condition
15 Jul 2026	8-K: Regulation FD Disclosure; Other Events
15 Jun 2026	Form 4: Royan Ajay, Director Bought 23,000 shares ($19.6K)
11 Jun 2026	Form 4: Bradley William, Director Bought 68,493 shares ($50.3K) · Granted 22,500 Stock Option
11 Jun 2026	Form 4: Conaway Samuel, Director Granted 22,500 Stock Option
11 Jun 2026	Form 4: Royan Ajay, Director Granted 22,500 Stock Option
11 Jun 2026	Form 4: Thompson Christopher Charles, Director Granted 22,500 Stock Option
11 Jun 2026	Form 4: Elia Marc, Director Granted 22,500 Stock Option
11 Jun 2026	Form 4: Barnes Kelly Ann, Director Granted 22,500 Stock Option
11 Jun 2026	Form 4: Meanwell Clive, Director Granted 22,500 Stock Option

Comments